Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endo-exonucleases are enzymes that possess both endonuclease and exonuclease activities, allowing them to cleave nucleic acids internally and from the ends. These enzymes play crucial roles in DNA repair, genetic recombination, and mutation avoidance. Examples include the MRX complex and the SbcCD complex. They are considered therapeutic targets due to their involvement in DNA processing and repair pathways. Inhibition or modulation of their activity could have implications for cancer treatment, antiviral strategies, or management of genetic disorders.
Inhibition of DNA repair, promotion of DNA degradation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endo-exonuclease (N/A).